Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Floy is a Munich-based healthtech company that develops artificial intelligence software designed to assist radiologists in identifying incidental findings in medical imaging. The company's platform integrates with existing clinical workflows to automatically screen CT and MRI scans for critical conditions that may not be the primary focus of the initial examination, such as aortic aneurysms or vertebral fractures. By enabling the early detection of these often asymptomatic conditions, Floy helps healthcare providers improve patient outcomes and generate additional value for radiology practices. The company primarily operates in the European market, partnering with private radiology clinics to enhance diagnostic accuracy and preventive care.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Floy Beauty.